Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

  • Opiant Pharma (NASDAQ:OPNT) stock increased by 112.9% to $20.22 during Monday's regular session. Trading volume for Opiant Pharma's stock is 1.0 million as of 12:30 EST. This is 7619.5% of its average full-day volume over the last 100 days. The company's market cap stands at $104.4 million. The company's, Q3 earnings came out today.
  • NeuBase Therapeutics (NASDAQ:NBSE) stock rose 42.82% to $0.31. Trading volume for this security as of 12:30 EST is 770.7K, which is 603.7% of its average full-day volume over the last 100 days. The company's market cap stands at $9.9 million.
  • PDS Biotechnology (NASDAQ:PDSB) shares moved upwards by 25.62% to $7.04. The current volume of 13.4 million shares is 5628.6% of PDS Biotechnology's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $200.2 million. The company's, Q3 earnings came out today.
  • Clovis Oncology (NASDAQ:CLVS) shares moved upwards by 24.1% to $0.36. Trading volume for this security as of 12:30 EST is 14.7 million, which is 400.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.9 million. The company's, Q3 earnings came out 3 days ago.
  • Cabaletta Bio (NASDAQ:CABA) stock moved upwards by 19.75% to $2.85. Trading volume for this security as of 12:30 EST is 838.1K, which is 41.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $82.6 million. The company's, Q3 earnings came out 2 days ago.
  • Cassava Sciences (NASDAQ:SAVA) shares rose 17.37% to $44.13. As of 12:30 EST, this security is trading at a volume of 2.4 million shares, making up 73.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion.

Losers

  • Satsuma Pharmaceuticals (NASDAQ:STSA) shares decreased by 83.5% to $0.67 during Monday's regular session. Satsuma Pharmaceuticals's stock is trading at a volume of 11.8 million shares as of 12:30 EST. This is 8578.9% of its average full-day volume over the last 100 days. The company's market cap stands at $22.1 million.
  • SELLAS Life Sciences Gr (NASDAQ:SLS) shares decreased by 41.32% to $2.67. Trading volume for this security as of 12:30 EST is 1.7 million, which is 623.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $54.8 million. As per the news, the Q3 earnings report came out today.
  • Nuwellis (NASDAQ:NUWE) stock declined by 38.46% to $0.12. As of 12:30 EST, this security is trading at a volume of 8.0 million shares, making up 237.0% of its average full-day volume over the last 100 days. The company's market cap stands at $3.8 million. As per the news, the Q3 earnings report came out 4 days ago.
  • POINT Biopharma Global (NASDAQ:PNT) shares decreased by 34.85% to $5.96. Trading volume for this security as of 12:30 EST is 3.7 million, which is 510.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $619.4 million.
  • MorphoSys (NASDAQ:MOR) shares decreased by 27.29% to $3.97. As of 12:30 EST, MorphoSys's stock is trading at a volume of 626.2K, which is 949.4% of its average full-day volume over the last 100 days. The company's market cap stands at $542.3 million.
  • Stoke Therapeutics (NASDAQ:STOK) stock fell 27.23% to $9.09. The current volume of 616.0K shares is 248.0% of Stoke Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $358.3 million. As per the news, the Q3 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.